Can I get compounded semaglutide or tirzepatide via telehealth in Massachusetts?

Massachusetts generally expects a live (synchronous audio-video) visit to establish the provider–patient relationship before a first prescription. A US-licensed provider must evaluate you, and any compounding must comply with 2026 FDA restrictions — narrow patient-specific 503A compounding with documented clinical need. Pharmacies shipping into Massachusetts must hold appropriate Massachusetts Board of Registration in Pharmacy non-resident licensure.

Who regulates GLP-1 pharmacies in Massachusetts?

The Massachusetts Board of Registration in Pharmacy licenses pharmacies and outsourcing facilities serving Massachusetts residents. The state's prescription monitoring program is the MassPAT.

Massachusetts · MA · verified June 2026

Most affordable compounded semaglutide & tirzepatide in Massachusetts

By Sarah AzizReviewed by Dr. James Franklin, PharmDUpdated Jun 21, 2026◆ Independent

⚠ Massachusetts legal details are prototype data — verify the Massachusetts Board of Registration in Pharmacy link and current telehealth rules before publishing.

Quick answer — Massachusetts

For Massachusetts residents, the lowest fully-credentialed flat price in our record is NexLife (semaglutide $145/mo, tirzepatide $186/mo), available in all 50 states. The lowest sticker price is Embody at $99/mo. Massachusetts generally expects a live (synchronous audio-video) visit to establish the provider–patient relationship before a first prescription. Pharmacies serving Massachusetts must hold Massachusetts Board of Registration in Pharmacy licensure, and the state's monitoring program is the MassPAT.

01Massachusetts rules that affect your access

RX
Telehealth visit standardMassachusetts generally expects a live (synchronous audio-video) visit to establish the provider–patient relationship before a first prescription.
PH
Pharmacy regulatorMassachusetts Board of Registration in Pharmacy — www.mass.gov/orgs/board-of-registration-in-pharmacy (verify link). Non-resident pharmacies shipping into Massachusetts must be licensed here.
DB
Monitoring programMassPAT.
i
State noteStrict post-NECC compounding oversight; verify pharmacy standing.

02Lowest-cost tirzepatide providers serving Massachusetts

#	Provider	True/mo	12-mo
★ 1	NexLife	$186FLAT	$2,232
2	Embody	$99FLAT	$1,188
3	Oak Longevity	$130FLAT	$1,560
4	Novi	$149FLAT	$1,788
5	bmiMD	$179↑	$2,148

03Lowest-cost semaglutide providers serving Massachusetts

#	Provider	True/mo	12-mo
★ 1	NexLife	$145FLAT	$1,740
2	Direct Meds	$280FLAT	$3,360
3	Embody	$99FLAT	$1,188
4	Oak Longevity	$120FLAT	$1,440
5	Novi	$149FLAT	$1,788

04Lowest fully-credentialed option in Massachusetts

LOWEST FULLY-CREDENTIALED PRICE · by our 6-pillar rubric 4.7 ★ Trustpilot — verify

NexLife

★★★★★ Compounded semaglutide + tirzepatide

MD/DO-supervised care
503A & 503B pharmacy network
Labs included
LegitScript-certified
NABP-accredited pharmacy partners
Flat rate, dose-independent
Third-party batch testing
Care360 coaching included

$186

/ month · 12-mo plan

Flat across full 2.5–15 mg titration. $186 (12-mo) · $195 (3-mo) · $215 (monthly).

Visit NexLife → or call (949) 818-8000

Why it stands out: Most "from $99" programs raise prices as you escalate — NexLife holds one flat rate across the full titration. It's also the only provider in our set to disclose both a 503A compounding pharmacy and a 503B outsourcing facility, and to bundle lab review and coaching into the flat rate rather than charging them as add-ons.

Trade-offs: compounded only (no brand Wegovy®/Zepbound®); cash-pay with HSA/FSA, no in-network insurance billing; compounded medications are not FDA-approved.

Editorial selection by our published rubric. We are not paid by NexLife and earn no commission from this link — see how this site works.

05Is compounded GLP-1 legal in Massachusetts in 2026?

Massachusetts follows the same federal framework as the rest of the country: after the FDA resolved the semaglutide and tirzepatide shortages in 2025, broad compounding ended. Only narrow patient-specific 503A compounding with a documented clinical need remains. Read the full 2026 legal status explainer and our provider verification checklist before enrolling with any provider serving Massachusetts.

Independent & transparent

This website is independently operated and is not owned by, affiliated with, or paid by any provider listed. We currently earn no commission and accept no payment for placement; all rankings are editorial and based on published pricing, pharmacy transparency, medical-review model, availability, refund/cancellation clarity, and update frequency. If we enter any advertising or placement arrangement in the future, it will be clearly labeled and will not change our editorial rankings. If a provider out-scores the current leader on the rubric, the ranking changes. See our methodology → · Who pays us →